AbbVie Inc. diskutieren
AbbVie Inc.
WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /
176,82 €
0,94 %
AbbVie Inc. (NYSE: ABBV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $200.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Morgan Stanley from $191.00 to $196.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Barclays PLC from $187.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Wells Fargo & Company from $200.00 to $205.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $210.00 price target on the stock, up previously from $195.00.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $200.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $200.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Morgan Stanley from $211.00 to $218.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie Inc. (NYSE: ABBV) had its price target raised by analysts at Piper Sandler from $196.00 to $209.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
Neueste Beiträge
StockNews_com in Spirit AeroSystems Holdings Inc diskutieren